Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 4,156,000 | 4,330,000 | 0 |
| Depreciation Amortization | 0 | 0 | 860,000 | 988,000 | 0 |
| Other Working Capital | 0 | 0 | -1,006,000 | 340,000 | 0 |
| Other Operating Activity | 0 | 0 | -248,000 | -1,475,000 | 2,125,000 |
| Operating Cash Flow | $0 | $0 | $3,762,000 | $4,183,000 | $2,125,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -1,538,000 | -1,423,000 | 0 |
| Net Acquisitions | 0 | 0 | 0 | -2,000 | 0 |
| Other Investing Activity | 0 | 0 | 367,000 | -1,103,000 | -1,216,000 |
| Investing Cash Flow | $0 | $0 | $-1,171,000 | $-2,528,000 | $-1,216,000 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -959,000 | -400,000 | -182,000 |
| Financing Cash Flow | $0 | $0 | $-959,000 | $-400,000 | $-182,000 |
| Net Cash Flow | $0 | $0 | $-396,000 | $640,000 | $-280,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 3,762,000 | 4,183,000 | 2,125,000 |
| Free Cash Flow | 0 | 0 | 3,762,000 | 4,183,000 | 2,125,000 |